Bupropion News and Research

RSS
Studies suggests that insular cortex may hold key to treating addiction

Studies suggests that insular cortex may hold key to treating addiction

S1 Biopharma supports FDA's approval of flibanserin for women living with HSDD

S1 Biopharma supports FDA's approval of flibanserin for women living with HSDD

New prescription smoking-cessation drug not helping smokers quit

New prescription smoking-cessation drug not helping smokers quit

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

People who quit smoking have improved metabolic effects, new study finds

People who quit smoking have improved metabolic effects, new study finds

GeneSight test better predicts antidepressant outcomes for patients with depression

GeneSight test better predicts antidepressant outcomes for patients with depression

Extending use of bupropion before quitting reduces smoking behavior

Extending use of bupropion before quitting reduces smoking behavior

Endocrine Society issues guideline on prescribing drugs to manage obesity, promote weight loss

Endocrine Society issues guideline on prescribing drugs to manage obesity, promote weight loss

Combination of behavioral support and medication helps people stop smoking

Combination of behavioral support and medication helps people stop smoking

FDA approves Contrave extended-release tablets for chronic weight management

FDA approves Contrave extended-release tablets for chronic weight management

Combining 2 smoking cessation therapies more effective for highly nicotine-dependent smokers

Combining 2 smoking cessation therapies more effective for highly nicotine-dependent smokers

New prescription weight-loss medication combines antidepressant with addiction medication

New prescription weight-loss medication combines antidepressant with addiction medication

Study: Combined medications may improve smoking cessation than single drug therapy

Study: Combined medications may improve smoking cessation than single drug therapy

Orexigen Therapeutics reports net loss of $18.6 million in Q3 2013

Orexigen Therapeutics reports net loss of $18.6 million in Q3 2013

Researchers study quality, effectiveness and safety of generic drugs used to treat depression

Researchers study quality, effectiveness and safety of generic drugs used to treat depression

IQWiG completes first health economic evaluation

IQWiG completes first health economic evaluation

Study assesses risk of psychiatric events in patients prescribed smoking cessation drugs

Study assesses risk of psychiatric events in patients prescribed smoking cessation drugs

Depressed smokers may benefit from mood management interventions

Depressed smokers may benefit from mood management interventions